HK1250752A1 - 治療骨髓增生性障礙的方法 - Google Patents
治療骨髓增生性障礙的方法Info
- Publication number
- HK1250752A1 HK1250752A1 HK18110217.6A HK18110217A HK1250752A1 HK 1250752 A1 HK1250752 A1 HK 1250752A1 HK 18110217 A HK18110217 A HK 18110217A HK 1250752 A1 HK1250752 A1 HK 1250752A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- myeloproliferative disorders
- treating myeloproliferative
- treating
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1716—Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562148005P | 2015-04-15 | 2015-04-15 | |
US201562218869P | 2015-09-15 | 2015-09-15 | |
PCT/US2016/027773 WO2016168612A1 (en) | 2015-04-15 | 2016-04-15 | Methods for treating myeloproliferative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1250752A1 true HK1250752A1 (zh) | 2019-01-11 |
Family
ID=57127338
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18110217.6A HK1250752A1 (zh) | 2015-04-15 | 2018-08-09 | 治療骨髓增生性障礙的方法 |
HK18115088.1A HK1256036A1 (zh) | 2015-04-15 | 2018-11-26 | 治療骨髓增生性障礙的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115088.1A HK1256036A1 (zh) | 2015-04-15 | 2018-11-26 | 治療骨髓增生性障礙的方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20180318303A1 (zh) |
EP (1) | EP3283655A4 (zh) |
JP (1) | JP2018512164A (zh) |
CN (1) | CN108138234A (zh) |
AU (1) | AU2016248317A1 (zh) |
CA (1) | CA2983004A1 (zh) |
HK (2) | HK1250752A1 (zh) |
RU (1) | RU2017139122A (zh) |
WO (1) | WO2016168612A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3054959B1 (en) | 2013-10-08 | 2020-01-08 | Promedior Inc. | Methods for treating fibrotic cancers |
JP6852397B2 (ja) | 2016-12-28 | 2021-03-31 | 株式会社島津製作所 | 分析用試料の調製方法および分析方法 |
CN110291089B (zh) | 2017-01-17 | 2022-05-27 | 海帕瑞吉尼克斯股份有限公司 | 用于促进肝再生或者减少或预防肝细胞死亡的蛋白激酶抑制剂 |
JP7248368B2 (ja) * | 2017-03-01 | 2023-03-29 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 高度に特異的な環状近接ライゲーションアッセイ |
DE102017107661A1 (de) * | 2017-04-10 | 2018-10-11 | Universität Rostock | SH2B-Adapterprotein-3 für die Vorhersage einer Knochenmarkantwort und Immunantwort |
TW202021626A (zh) * | 2018-07-31 | 2020-06-16 | 美商傑龍公司 | 辨識有可能受益於以端粒酶抑制劑治療之患者的方法 |
KR101962869B1 (ko) * | 2018-08-02 | 2019-03-27 | 주식회사 우리메디칼 | 이미지 분석에 기반한 골수판독 지원 장치 |
CN113508128A (zh) * | 2019-03-01 | 2021-10-15 | 艾洛基治疗公司 | 组成型活性嵌合细胞因子受体 |
MX2021010444A (es) | 2019-03-01 | 2021-09-21 | Allogene Therapeutics Inc | Receptores de citocinas quimericos que tienen un ectodominio de pd-1. |
CN111471096B (zh) * | 2020-01-15 | 2022-02-18 | 上海众启生物科技有限公司 | 用于阿尔茨海默症自身抗体检测的含有adarb1蛋白片段组合物 |
EP3900789A1 (en) * | 2020-04-23 | 2021-10-27 | Universitätsklinikum Jena | Pharmaceutical combination for the treatment of myeloproliferative neoplasms |
CN113549597B (zh) * | 2021-07-22 | 2022-03-25 | 浙江大学 | 一种人原发性骨髓纤维化细胞株及其应用 |
CN114752575B (zh) * | 2022-04-07 | 2023-06-13 | 内蒙古工业大学 | 一种nad+依赖性脱氢酶基因及其在提高辅酶q10产量中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2877013A1 (fr) * | 2004-10-27 | 2006-04-28 | Assist Publ Hopitaux De Paris | Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez |
US8329659B2 (en) * | 2009-06-17 | 2012-12-11 | Promedior, Inc. | SAP variants and their use |
EP3054959B1 (en) * | 2013-10-08 | 2020-01-08 | Promedior Inc. | Methods for treating fibrotic cancers |
-
2016
- 2016-04-15 EP EP16780843.5A patent/EP3283655A4/en not_active Withdrawn
- 2016-04-15 RU RU2017139122A patent/RU2017139122A/ru unknown
- 2016-04-15 JP JP2017554345A patent/JP2018512164A/ja active Pending
- 2016-04-15 CN CN201680034923.6A patent/CN108138234A/zh active Pending
- 2016-04-15 AU AU2016248317A patent/AU2016248317A1/en not_active Abandoned
- 2016-04-15 WO PCT/US2016/027773 patent/WO2016168612A1/en active Application Filing
- 2016-04-15 CA CA2983004A patent/CA2983004A1/en not_active Abandoned
- 2016-04-15 US US15/566,692 patent/US20180318303A1/en not_active Abandoned
-
2018
- 2018-08-09 HK HK18110217.6A patent/HK1250752A1/zh unknown
- 2018-11-26 HK HK18115088.1A patent/HK1256036A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2983004A1 (en) | 2016-10-20 |
HK1256036A1 (zh) | 2019-09-13 |
RU2017139122A (ru) | 2019-05-15 |
RU2017139122A3 (zh) | 2019-08-28 |
AU2016248317A1 (en) | 2017-11-09 |
CN108138234A (zh) | 2018-06-08 |
EP3283655A4 (en) | 2018-12-05 |
WO2016168612A1 (en) | 2016-10-20 |
EP3283655A1 (en) | 2018-02-21 |
JP2018512164A (ja) | 2018-05-17 |
US20180318303A1 (en) | 2018-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1259336A1 (zh) | 用於治療骨髓增生性病症的方法 | |
HK1252741A1 (zh) | 用於治療神經疾病的組合物和方法 | |
IL285151A (en) | Methods for the treatment of fgf21-related disorders | |
HK1256036A1 (zh) | 治療骨髓增生性障礙的方法 | |
ZA201705673B (en) | Methods for treating skin | |
IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
EP3380121A4 (en) | METHOD FOR THE TREATMENT OF EYE DISEASES | |
HK1244217A1 (zh) | 用於治療蛋白質病的方法 | |
IL250715A0 (en) | Preparations and methods for the treatment of cultural disorders | |
IL247699A0 (en) | Preparations and methods for the treatment of kidney disorders | |
PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
EP3166610A4 (en) | Methods for treating neurologic disorders | |
HK1252996A1 (zh) | 用於治療癲癇的方法 | |
HK1251965A1 (zh) | 用於治療癲癇的方法 | |
HK1245127A1 (zh) | 治療腦疾病的方法和組合物 | |
HK1248133A1 (zh) | 治療神經母細胞瘤的方法 | |
SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
IL254336A0 (en) | A new treatment method | |
HK1256371A1 (zh) | 用於治療腫瘤的方法 | |
GB201602011D0 (en) | Treating skin disorders | |
GB201517995D0 (en) | Products for treating psychogenic pain disorders | |
GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders | |
GB201413532D0 (en) | Combination therapy for treating hearing disorders |